Rossari Biotech Ltd - Stock Valuation and Financial Performance

BSE: 543213 | NSE: ROSSARI | Chemicals | Small Cap

Rossari Biotech Share Price

802.90 -6.15 -0.76%
as on 12-Jul'24 16:01

DeciZen - make an informed investing decision on Rossari Biotech

Overall Rating
Bole Toh

1. Quality

2. Valuation


3. Price Trend

Rossari Biotech stock performance -

mw4me loader
P/E Ratio (CD):
Market Cap:
4,435.8 Cr.
52-wk low:
52-wk high:

Is Rossari Biotech Ltd an attractive stock to invest in?

1. Is Rossari Biotech Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Rossari Biotech Ltd is a average quality company.

2. Is Rossari Biotech Ltd undervalued or overvalued?

The key valuation ratios of Rossari Biotech Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Rossari Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Rossari Biotech Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Rossari Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Rossari Biotech Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 8.3%7.9%7.2%21.6%29.2%39.2%27.6%21.4%16.1%13%-
Value Creation

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1551711792332925166007091,4831,6561,831
Sales YoY Gr.-10.4%4.4%30.6%25%76.9%16.3%18.2%109.1%11.7%-
YoY Gr.--3.8%-7.9%364.3%81.9%60.1%33.1%21.8%6%12.9%-
BVPS (₹) 9.19.710.313.519.525.656.478.3145.7165.3189.7
Adj Net
Cash Flow from Ops.
Debt/CF from Ops.


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 30.1%41.5%40.3%11.7%
Adj EPS 41.8%25.4%13.4%12.9%
Share Price - - -11.7% -7.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on
Equity %
Op. Profit
Mgn %
Net Profit
Mgn %
Debt to
Working Cap
Cash Conv.

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 40.26%

Net Profit is growing at healthy rate in last 3 years 13.36%

Sales growth is good in last 4 quarters at 10.89%

Return on Equity has declined versus last 3 years average to 13.30%

Latest Financials - Rossari Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) 18 23.7
TTM Sales (₹ Cr.) 1,203 1,831
BVPS (₹.) 173.8 189.7
Reserves (₹ Cr.) 949 1,037
P/BV 4.62 4.23
PE 44.52 33.94
From the Market
52 Week Low / High (₹) 657.80 / 903.45
All Time Low / High (₹) 536.10 / 1620.60
Market Cap (₹ Cr.) 4,436
Equity (₹ Cr.) 11.1
Face Value (₹) 2
Industry PE 56.6

Management X-Ray of Rossari Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Rossari Biotech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
Operating Expenses 1401561662092474394955861,3071,441
Manufacturing Costs444631314213849
Material Costs1081231311661973393724621,1081,171
Employee Cost 11111214202837426899
Other Costs 181820232859736193123
Operating Profit 151513244578105123176215
Operating Profit Margin (%) 9.5%8.5%7.0%10.4%15.3%15.0%17.5%17.3%11.9%13.0%
Other Income 000111491914
Interest 554213431322
Depreciation 555451217234863
Exceptional Items 0000000000
Profit Before Tax 45519406388107136144
Tax 1113111823273937
Profit After Tax 443162946658098107
PAT Margin (%) 2.5%2.2%1.9%6.7%9.9%8.8%10.9%11.3%6.6%6.5%
Adjusted EPS (₹)
Dividend Payout Ratio (%)6%6%0%0%30%5%4%3%3%3%

Balance Sheet

(All Figures are in Crores.)

Equity and Liabilities

Shareholders Fund 4447506594124286407802912
Share Capital 44444410101111
Reserves 4042466190119276396791901
Minority Interest0000000000
Long Term Debt797211340035
Short Term Debt29301520193270029
Trade Payables281828324010697131186185
Others Liabilities 171085114980107429411
Total Liabilities 1251141091241662835256451,4171,572

Fixed Assets

Gross Block676738768886122234704741
Accumulated Depreciation25300384312295397158
Net Fixed Assets42383838457494181607584
CWIP 7788103220116
Investments 0000701803651
Trade Receivables28303147608694144305354
Cash Equivalents 1132161278852125
Others Assets5755859112135225254
Total Assets 1251141091241662835256451,4171,572

Cash Flow

(All Figures are in Crores.)
Cash Flow From Operating Activity 1582672471574829152
PBT 45519406388107136144
Adjustment 1097661720215583
Changes in Working Capital 1-513-14-1111-31-48-112-27
Tax Paid -1-1-1-3-11-20-20-31-50-48
Cash Flow From Investing Activity -4-2-5-6-20-36-190-37-299-181
Capex -4-2-5-6-14-44-76-56-36-31
Net Investments 000007-1814-6-14
Others 0000-71-965-257-136
Cash Flow From Financing Activity -11-6-19-2-5-29157-2529261
Net Proceeds from Shares 000000100433024
Net Proceeds from Borrowing 00000-139-34045
Interest Paid -5-5-3-2-1-2-3-4-2-6
Dividend Paid 00000-11-3-3-3-3
Others -6-2-170-4-1624-27-521
Net Cash Flow 0020-2623-142232
ROE (%)
ROCE (%)10.6910.710.326.440.3754.437.9328.8124.3718.48
Asset Turnover Ratio1.241.431.622.062.31.491.221.451.12
PAT to CFO Conversion(x)3.7528.670.440.831.540.880.60.31.42
Working Capital Days
Receivable Days66626261665154615572
Inventory Days99785838363234393541
Payable Days946865666779100905258

Rossari Biotech Ltd Stock News

Rossari Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Rossari Biotech on 12-Jul-2024 16:01 is ₹802.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Jul-2024 16:01 the market cap of Rossari Biotech stood at ₹4,435.8.
The latest P/E ratio of Rossari Biotech as of 12-Jul-2024 16:01 is 44.52.
The latest P/B ratio of Rossari Biotech as of 12-Jul-2024 16:01 is 4.62.
The 52-week high of Rossari Biotech is ₹903.5 and the 52-week low is ₹657.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rossari Biotech is ₹1,203 ( Cr.) .

About Rossari Biotech Ltd

The company was initially incorporated as Rossari Labtech on March 6, 2003, as a partnership firm under the Indian Partnership Act, 1932, pursuant to a certificate of registration dated June 22, 2003, issued by the Registrar of Firms, Mumbai. The name of the partnership firm was changed to Rossari Biotech on December 5, 2003 and further the firm converted into a joint stock company on August 10, 2009, under part IX of the Companies Act, 1956 as Rossari Biotech Limited with a certificate of incorporation granted by the Registrar of Companies, Maharashtra at Mumbai (RoC). The company received its certificate of commencement of business on August 13, 2009.

Business area of the company

The company is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. The company’s business is organized in three main product categories - (i) home, personal care and performance chemicals; (ii) textile specialty chemicals; and (iii) animal health and nutrition products.

The company is the leading manufacturer of acrylic polymers in India and manufactures many products for its customers in the soaps and detergent, paints, inks and coatings, ceramics and tiles, water treatment chemicals and pulp and paper industries. It also manufacture institutional cleaning chemical formulations for hospitality, facility management, airports, corporates, food service, commercial laundry, malls, multiplexes, educational sector, places of worship etc. It is in advanced stages of expanding its home, personal care and performance product portfolio to water treatment formulations, specialty formulation for breweries as well as dairies. Besides, the company provides specialty chemicals for the entire value-chain of the textile industry starting from fiber, yarn to fabric, wet processing and garment processing. The company has also diversified into animal health and nutrition and currently supply poultry feed supplements and additives, pet grooming and pet treats including for weaning, infants and adult pets.

Major Events & Milestones:

  • 2003: The company’s Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India.
  • 2004: Established first manufacturing facility at Silvassa.
  • 2009: Conversion of partnership firm into company.
  • 2009: Incorporation of company.
  • 2009: Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research.
  • 2010: Forayed into animal health and nutrition products.
  • 2013: Forayed into HPPC products.
  • 2014: The company’s Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari.
  • 2015: Lease granted by GIDC to company for setting up manufacturing facility at Dahej.
  • 2017: The Food Safety Management System of Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015.
  • 2018: Entered into an exclusive purchasing agreement with Hindustan Unilever.
  • 2020: Completion of the Pre-IPO Placement.

Awards & accreditations:

  • 2009: The erstwhile Hon’ble Union Finance Minister Pranab Mukherjee awarded ‘Corp EXCEL 2008– National mSME’ form a list of 27000 companies.
  • 2010: Frost & Sullivan awarded ‘Customer Value Enhancement for Industrial Enzymes Market’.
  • 2011: The Council for Fair Business Practices awarded ‘CFBP – Jamnalal Bajaj Uchit Vyavahar Puraskar for Fair Business Practices’.
  • 2017: The India SME Forum awarded at the India SME 100 Awards for ‘scoring in the top 100 in the overall evaluation of Financial & Non - Financial Parameters amongst 33102 nominations’.
  • 2018: Arvind awarded ‘Star Performer Award 2018’ in the Dye & Chemicals Category.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.